T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?
about
Recent advances in understanding and treating vasculitisImmune aging and autoimmunity.Increased Circulating Th17 Cells, Serum IL-17A, and IL-23 in Takayasu ArteritisCD4 cell count and CD4/CD8 ratio increase during rituximab maintenance in granulomatosis with polyangiitis patientsAbnormal expression pattern of the IL-2 receptor β-chain on CD4+ T cells in ANCA-associated vasculitis.Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis.Cellular and molecular mechanisms of autoimmune disease.Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.Biomarkers in ANCA-associated vasculitis.Complement in ANCA-associated vasculitis.Vasculitides and the Complement System: a Comprehensive Review.A functional (pro)renin receptor is expressed in human lymphocytes and monocytes.A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.Endothelial progenitor cells are differentially impaired in ANCA-associated vasculitis compared to healthy controls.Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over.Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapyCurrent and novel biomarkers in anti-neutrophil cytoplasm-associated vasculitis.Regulatory B cells in ANCA-associated vasculitis.T-cell regulation in Erythema Nodosum Leprosum.Towards precision medicine in ANCA-associated vasculitis.B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.[T-cells in ANCA-associated vasculitis].
P2860
Q26747046-67B145B8-DAFA-4299-858B-A0CA2630D03DQ34777989-C2CEE11D-D1FA-449E-98A7-F75E6DAF3BD1Q36731105-08B8DD2C-0CDC-413F-B22E-E809E61B1B50Q37282164-096B3F2D-9365-4C29-8643-F49EE3224FCEQ37600604-0B81498C-8EA5-4ADE-AB84-C975D7755C4AQ37855477-3D7AF565-055B-4144-A26C-DE7E62F0BB73Q37959331-77B75C8D-4660-4EA3-874E-EEF9219B29D8Q38076499-5C5CA7D7-3998-47D2-AA32-46822121D6EDQ38129720-35AF1577-D74E-41C2-8F73-4D24E63F2AD6Q38155653-1F5D52AC-4A1D-4F99-AFF0-766A2A9165ABQ38259908-29D78AFB-013E-4EC9-B7B5-911B53E9813BQ38928804-A359285A-7699-47E9-A8B6-EAA4CBBC7AFAQ39317812-38B564A7-A462-45B7-A483-D90BE73B6073Q40638676-CBD66653-9409-49FE-9B1E-081EDCFF4B31Q41718154-BB2434D3-8E64-4D06-84DA-3B40E112B482Q41864176-448C5A7C-8DBF-4894-B2F7-8C68A9B6A074Q41892986-8CBA7C79-8E3F-4EED-B733-9399DDE5C1AEQ45840349-D04247CB-7431-4A88-809D-6298B36F4023Q47131276-6527878F-ECEB-4791-96F5-034F2C59E7FAQ50089937-D32422B7-458F-4C61-ABE0-EC5DE96D9E8BQ50897604-5403F53C-0EBE-45FE-A802-DB0F02874910Q50988915-CA839FF4-FEED-464C-A5CD-E1662D8B3BEA
P2860
T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T cells in ANCA-associated vas ...... al versus circulating T cells?
@en
T cells in ANCA-associated vas ...... al versus circulating T cells?
@nl
type
label
T cells in ANCA-associated vas ...... al versus circulating T cells?
@en
T cells in ANCA-associated vas ...... al versus circulating T cells?
@nl
prefLabel
T cells in ANCA-associated vas ...... al versus circulating T cells?
@en
T cells in ANCA-associated vas ...... al versus circulating T cells?
@nl
P2093
P2860
P356
P1476
T cells in ANCA-associated vas ...... al versus circulating T cells?
@en
P2093
Benjamin Wilde
Jan Damoiseaux
Marielle Thewissen
Oliver Witzke
Pieter van Paassen
P2860
P2888
P356
10.1186/AR2923
P577
2010-02-24T00:00:00Z
P5875
P6179
1022364160